Table 4 Absorbed effective dose in Chinese HVs
From: Safety, biodistribution and radiation dosimetry of [123I]ioflupane in healthy Chinese volunteers
Target organ | Absorbed dose (mGy/MBq) ± SD |
|---|---|
Urinary bladder wall | 0.060 ± 0.01423 |
LLI wall | 0.052 ± 0.01653 |
Lungs | 0.052 ± 0.00706 |
ULI wall | 0.048 ± 0.01548 |
Liver | 0.035 ± 0.00838 |
Bone surfaces (osteogenic cells) | 0.033 ± 0.00504 |
Gallbladder wall | 0.030 ± 0.00540 |
Small intestine | 0.026 ± 0.00675 |
Heart wall | 0.024 ± 0.00478 |
Brain | 0.021 ± 0.00573 |
Stomach | 0.021 ± 0.00439 |
Ovaries | 0.020 ± 0.00451 |
Uterus | 0.018 ± 0.00281 |
Spleen | 0.018 ± 0.00550 |
Pancreas | 0.016 ± 0.00194 |
Thyroid | 0.016 ± 0.00471 |
Adrenals | 0.015 ± 0.00161 |
Kidneys | 0.013 ± 0.00150 |
Thymus | 0.012 ± 0.00149 |
Muscle | 0.011 ± 0.00138 |
Red marrow | 0.010 ± 0.00129 |
Breasts | 0.009 ± 0.00098 |
Testes | 0.008 ± 0.00091 |
Skin | 0.006 ± 0.00086 |
Total body | 0.013 ± 0.00162 |
Effective dose (mSv/MBq) | 0.028 ± 0.00448 |